Transcranial magnetic stimulation combined with virtual reality improves quality of life in patients with Parkinson’s disease with depression - Report - MDSpire
Advertisement
Transcranial magnetic stimulation combined with virtual reality improves quality of life in patients with Parkinson’s disease with depression
Clinical Report: Enhancing Quality of Life in Parkinson's Disease Patients
Overview
This study investigates the effects of combining transcranial magnetic stimulation (TMS) with virtual reality (VR) on quality of life and depressive symptoms in patients with Parkinson's disease and depression (PD-D). Results indicate that the combination therapy significantly improves depression, anxiety, motor function, and overall quality of life compared to TMS alone.
Background
Parkinson's disease (PD) is a prevalent neurodegenerative disorder often accompanied by depression, which affects 40-50% of patients. Depression in PD not only exacerbates motor dysfunction but also severely impacts the quality of life. Current treatments are limited by side effects and invasiveness, highlighting the need for innovative, non-invasive therapies.
Data Highlights
Group
Pre-Treatment Scores
Post-Treatment Scores
p-value
TMS
HAMA-14, HAMD-17, UPDRS-III, PDQ-39
Significant decrease
p < 0.05
TMS + VR
HAMA-14, HAMD-17, UPDRS-III, PDQ-39
More pronounced decrease
p < 0.001
Key Findings
The study included 190 patients with PD-D after applying inclusion and exclusion criteria.
Both TMS and TMS + VR groups showed significant improvements in depression and anxiety symptoms post-treatment.
Motor function and quality of life scores improved significantly in both groups, with greater improvements in the TMS + VR group.
No significant difference in adverse effects was observed between the two treatment groups.
The combination of TMS and VR offers a new approach for personalized treatment of PD-D.
Clinical Implications
The findings suggest that combining TMS with VR may enhance treatment outcomes for patients with PD-D, potentially leading to better management of depressive symptoms and improved quality of life. Clinicians may consider this combination therapy as a viable option in treatment plans.
Conclusion
The combination of TMS and VR significantly enhances the treatment of depression and motor function in PD-D patients, indicating a promising direction for future therapeutic strategies.
